DOCSLIB.ORG

ABSTRACT: Setting: DNA Methylation Is an Epigenetic Mechanism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ABSTRACT: Setting: DNA Methylation Is an Epigenetic Mechanism ABSTRACT: Setting: DNA methylation is an epigenetic mechanism through which environmental factors including obesity influence health. Obesity is a major modifiable risk factor for many common diseases including cardiovascular diseases and cancer. Obesity- 5 induced metabolic stress and inflammation are key mechanisms that affect disease risk and which may result from changes in methylation of metabolic and inflammatory genes. Objectives: This review aims to report the effects of weight loss induced by bariatric surgery (BS) on DNA methylation in adults with obesity focusing on changes in 10 metabolic and inflammatory genes. Methods: A systematic review was performed using Medline, EMBASE and Scopus, to identify studies in adult humans that reported DNA methylation following BS. Results: Out of 15996 screened titles, 15 intervention studies were identified, all of which reported significantly lower body mass index (BMI) post-surgery. DNA 15 methylation was assessed in five different tissues (blood=7 studies, adipose tissues =4, skeletal muscle =2, liver and spermatozoa). Twelve studies reported significant changes in DNA methylation after BS. Meta-analysis showed that BS increased methylation of PDK4 loci in skeletal muscle and blood in two studies while the effects of BS on IL6 methylation levels in blood were inconsistent. BS had no overall effect 20 on LINE1 or PPARGC1 methylation. Conclusion: The current evidence supports the reversibility of DNA methylation at specific loci in response to BS-induced weight loss. These changes are consistent with improved metabolic and inflammatory profiles of patients after BS. However, the 1 evidence regarding the effects of BS on DNA methylation in humans is limited and 25 inconsistent, which makes it difficult to combine and compare data across studies. Key words: Bariatric surgery, DNA methylation, obesity, inflammation 30 35 40 2 Introduction: 45 Obesity is a major modifiable, and preventable, risk factor for many common diseases including cardiovascular diseases and cancer1. Obesity increases disease risk by multiple mechanisms, including increased metabolic stress and chronic inflammation. Obesity-induced inflammation is orchestrated by metabolic cells, results in local expression of inflammatory mediators and creates a proinflammatory 50 tissue environment that is maintained in the long-term.2 This dysregulated metabolism is characterised by abnormal glucose metabolism, dyslipidemia and insulin resistance which subsequently increase the inflammatory response3. These effects lead to endothelial dysfunction and atherosclerosis, increasing the risk of cardiovascular diseases4. In addition, these mechanisms may underpin the greater 55 cancer risk in those with obesity.3 DNA methylation is an epigenetic mechanism through which obesity may influence disease risk. In humans, DNA is methylated by the addition of a methyl group to the 5’ position on cytosine (C) residues in CpG dinucleotides and is a key element in the regulation of gene expression5. Abnormal patterns of DNA methylation result in 60 reduced DNA integrity, changes in gene expression and mutations6. Patterns of DNA methylation respond to many environmental factors, including dietary interventions and weight loss7. Bariatric surgery (BS) is an effective therapy which induces long-term weight loss and improves comorbidities in obese patients.8 BS induces remission from type 2 65 diabetes (T2D) in a large proportion of initially obese patients, lowers risk of cardiometabolic disease9 and lowers incident cancer risk including breast, endometrial and colorectal cancers10. However, whilst these changes are associated 3 with decreased systemic and adipose tissue inflammation11, the underlying molecular mechanisms remain unresolved. 70 This systematic review reports the effects of weight loss induced by BS on DNA methylation in adults with obesity, aiming to: i) synthesize the evidence for the relationships between weight loss and corresponding changes in DNA methylation and ii) establish the links between these changes and specific metabolic and inflammatory genetic loci. 75 Methods: The systematic review is reported following the PRISMA checklist and flowchart12 (Supplementary Figure1). The systematic review was registered with PROSPERO (CRD42018112261). 80 Search strategy and screening: The databases, Embase, Scopus and Medline, were searched from inception until January 2019 by using the following search terms: ( ( (methylat*) OR methylation [Mesh] OR dna methylation [Mesh] ) AND ( ( Surg*) OR Surgery [Mesh] OR Bariatric Surgery [Mesh] ) ). Other databases that were searched included: Prospero, 85 Cochrane library, ClinicalTrial.gov and International clinical trials registry platform (WHO) for relevant protocols of clinical trials and systematic reviews that addressed DNA methylation and bariatric surgery. Articles were screened against the pre-set inclusion criteria (PICOS): a) Population: adult human beings (≥16 years old); b) Intervention: bariatric surgical interventions or 90 procedures; c) Comparator: healthy control group, other bariatric interventions, and 4 other interventions aiming for weight loss including dietary and physical exercise; d) Outcome: DNA methylation measured using any technique (global or locus specific) as a primary or secondary outcome, assessed before and after the intervention; e) Study design: any observational or intervention study, randomized or non- 95 randomized. Studies that recruited patients who had a history of, or were undergoing active treatment for, specific diseases (e.g. cancer) or patients with hereditary genetic disorders were excluded because of the likelihood that such conditions or therapies would confound the intervention effects. Titles and abstracts were screened by two independent reviewers (KE and FCM). 100 Neither of the reviewers was blind to the journal titles or to the study authors or institutions. Following screening of the titles and abstracts, full texts were reviewed to ensure eligibility for inclusion. Comparisons were made between the results of the two reviewers. Any discrepancy between their decisions regarding inclusion in the study was resolved by a third reviewer (JCM). 105 Data extraction, narrative synthesis and meta-analysis: The following data were collected using a pre-tested standard form: year of publication; study design; health or disease status of participants; number of participants; BMI of participants before and after intervention; nature of bariatric 110 intervention; duration of follow up; any other pre-procedure intervention; nature of other interventions; sample site; DNA methylation assessment method (including genomic loci, where appropriate), and DNA methylation levels of participants pre- and post- intervention, with measures of variance and level of significance. These 5 data were recorded using Microsoft® Excel 2017 which was used to synthesize 115 descriptive statistics and summary tables to support the narrative synthesis. Eligible studies were included in a meta-analysis conducted using the Review Manager software (v5.3, The Cochrane Collaboration, 2014) and intervention effects were quantified using a random effects model (due to heterogeneity) and standardized mean difference (due to the different methods used to quantify DNA 120 methylation). The quality of the included studies was assessed using the Newcastle- Ottawa Scale (NOS). Heterogeneity between studies was assessed using the Chi2 statistic (expressed as p value) and I2 statistics (expressed as percentage) using Review Manager v5.3. 125 Results: The PRISMA flowchart12 (Supplementary Figure 1) summarizes the outcomes of the search strategy. Out of 15996 screened titles, 15 studies were included. Of these studies, two were cross sectional and eight were cohort, three of which did not include a control group. None of the studies was a randomized controlled trial (RCT) 130 (Table 1). Two BS procedures were applied in the included studies: Roux-en-Y Gastric Bypass (RYGB, n=15) and Sleeve Gastrectomy (SG, n=3). In the fifteen studies, 312 obese patients underwent BS (range 6 – 120 patients, median =11) with an average follow up of 10.1 months (range 6 – 24 months). Mean BMI dropped from 45.9 kg/m2 (42.1- 135 50.9) to 32.8 kg/m2 (25.7-36.4) after BS. Only three studies13–15 reported mean BMI below the obesity cutoff (30) at ≥ 12-month follow-up. DNA methylation was 6 assessed in five different tissues: blood (n=7), adipose tissues (n=4), skeletal muscles (n=2), liver (n=1) and spermatozoa (n=1) (Table1). 140 Effects of bariatric surgery on DNA methylation in blood: Five studies investigated the effects of BS on DNA methylation at specific genomic loci in blood. Kirchner et al.13 followed up 7 patients who had undergone RYGB and for whom mean BMI was 27.3 kg/m2 after 12-month follow-up. Methylation of PDK4 (Pyruvate Dehydrogenase Kinase 4) (involved in metabolic homeostasis), IL1-B 145 (Interleukin 1 beta), IL6 (Interleukin 6) and TNF (Tumor Necrosis Factor) (inflammatory genes) in whole blood was significantly higher at the end of the 12- month follow-up compared with pre-surgery levels. In addition, methylation of IL1-B, IL6 and TNF and PPARGC1A (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha gene) was lower immediately after surgery (two days), indicating 150 that the effects of acute stress by BS on the inflammatory process may mediated through these hypomethylated inflammatory genes. Nicoletti et al16 investigated the effects of BS on the methylation
Load more

Recommended publications
  • SH3 Interactome Conserves General Function Over Specific Form
    SH3 Interactome Conserves General Function Over Specific Form Xiaofeng Xin, David Gfeller, Jackie Cheng, Raffi Tonikian, Lin Sun, Ailan Guo, Lianet Lopez, Alevtina Pavlenco, Adenrele Akintobi, Yingnan Zhang, Jean-Francois Rual, Bridget Currell, Somasekar Seshagiri, Tong Hao, Xinping Yang, Yun A. Shen, Kourosh Salehi-Ashtiani, Jingjing Li, Aaron T. Cheng, Dryden Bouamalay, Adrien Lugari, David E. Hill, Mark L. Grimes, David G. Drubin, Barth D. Grant, Marc Vidal, Charles Boone, Sachdev S. Sidhu, Gary D. Bader. Table of content: 1. Supplementary Information – Data analysis 2. Supplementary Figures 1-13 3. Supplementary Tables 1-19 4. References 1. Supplementary Information Data analysis Domain-protein two-way clustergram The domain-protein two-way clustergram in Supplementary Figure 5 was generated as previously described (Jin et al, 2009), with some modifications. In particular, similarities were computed between protein-domain profiles (defined by the set of domains on each protein) and domain-protein profiles (defined by the set of proteins for each domain) using the Jaccard similarity coefficient (size of the intersection divided by the size of the union of the sets). Domain annotation was obtained from SMART (Letunic et al, 2009; Schultz et al, 2000). This yielded statistical descriptions of the relatedness of any two proteins, based on their domain compositions, and of the relationship between any two domains based on their co-occurrence among proteins. Complete linkage hierarchical clustering was then used to cluster rows and columns of the matrix and produce a two-way clustergram of the yeast and worm SH3 protein sets. The clustergrams were generated using the MATLAB Bioinformatics Toolbox.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • The Landscape of Human Mutually Exclusive Splicing
    bioRxiv preprint doi: https://doi.org/10.1101/133215; this version posted May 2, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. The landscape of human mutually exclusive splicing Klas Hatje1,2,#,*, Ramon O. Vidal2,*, Raza-Ur Rahman2, Dominic Simm1,3, Björn Hammesfahr1,$, Orr Shomroni2, Stefan Bonn2§ & Martin Kollmar1§ 1 Group of Systems Biology of Motor Proteins, Department of NMR-based Structural Biology, Max-Planck-Institute for Biophysical Chemistry, Göttingen, Germany 2 Group of Computational Systems Biology, German Center for Neurodegenerative Diseases, Göttingen, Germany 3 Theoretical Computer Science and Algorithmic Methods, Institute of Computer Science, Georg-August-University Göttingen, Germany § Corresponding authors # Current address: Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland $ Current address: Research and Development - Data Management (RD-DM), KWS SAAT SE, Einbeck, Germany * These authors contributed equally E-mail addresses: KH: [email protected], RV: [email protected], RR: [email protected], DS: [email protected], BH: [email protected], OS: [email protected], SB: [email protected], MK: [email protected] - 1 - bioRxiv preprint doi: https://doi.org/10.1101/133215; this version posted May 2, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Vinexin Family (SORBS) Proteins Play Different Roles in Stiffness- Sensing and Contractile Force Generation Takafumi Ichikawa1,2, Masahiro Kita1, Tsubasa S
    © 2017. Published by The Company of Biologists Ltd | Journal of Cell Science (2017) 130, 3517-3531 doi:10.1242/jcs.200691 RESEARCH ARTICLE Vinexin family (SORBS) proteins play different roles in stiffness- sensing and contractile force generation Takafumi Ichikawa1,2, Masahiro Kita1, Tsubasa S. Matsui3,4, Ayaka Ichikawa Nagasato1, Tomohiko Araki3, Shian-Huey Chiang5, Takuhito Sezaki1, Yasuhisa Kimura1, Kazumitsu Ueda1,2, Shinji Deguchi3,4, Alan R. Saltiel5,* and Noriyuki Kioka1,2,‡ ABSTRACT generating actin stress fibers (SFs) (Geiger et al., 2001). This Vinexin, c-Cbl associated protein (CAP) and Arg-binding protein 2 ‘ ’ (ArgBP2) constitute an adaptor protein family called the vinexin mechanical linkage acts as a molecular clutch to transmit the force (SORBS) family that is targeted to focal adhesions (FAs). Although derived from non-muscle myosin-II-dependent contraction to the numerous studies have focused on each of the SORBS proteins and ECM. Cells on more rigid substrates exert greater contractile forces partially elucidated their involvement in mechanotransduction, a than those on soft substrates (Hoffman et al., 2011; Roca-Cusachs comparative analysis of their function has not been well addressed. et al., 2012; LaCroix et al., 2015). These alterations can lead to Here, we established mouse embryonic fibroblasts that individually stiffness-dependent biochemical signals. Among the numerous FA scaffolding proteins, vinculin is one of expressed SORBS proteins and analysed their functions in an ‘ ’ identical cell context. Both vinexin-α and CAP co-localized with the main clutch molecules that can regulate force transmission. vinculin at FAs and promoted the appearance of vinculin-rich FAs, Vinculin consists of an N-terminal head region and a C-terminal tail α region separated by a flexible proline-rich linker region (Bakolitsa whereas ArgBP2 co-localized with -actinin at the proximal end of – FAs and punctate structures on actin stress fibers (SFs), and induced et al., 2004; Borgon et al., 2004).
    [Show full text]
  • Cyclin a Triggers Mitosis Either Via Greatwall Or Cyclin B
    bioRxiv preprint doi: https://doi.org/10.1101/501684; this version posted December 20, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Cyclin A triggers Mitosis either via Greatwall or Cyclin B Nadia Hégarat(1)*, Adrijana Crncec(1)*, Maria F. Suarez Peredoa Rodri- guez(1), Fabio Echegaray Iturra(1), Yan Gu(1), Paul F. Lang(2), Alexis R. Barr(3), Chris Bakal(4), Masato T. Kanemaki(5), Angus I. Lamond(6), Bela Novak(2), Tony Ly(7)•• and Helfrid Hochegger(1)•• (1) Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN19RQ, UK (2) Department of Biochemistry, University of Oxford, South Park Road, Oxford OX13QU, UK (3) MRC London Institute of Medical Science, Imperial College, London W12 0NN, UK (4) The Institute of Cancer Research, London SW3 6JB, UK (5) National Institute of Genetics, Research Organization of Information and Sys- tems (ROIS), and Department of Genetics, SOKENDAI (The Graduate University of Advanced Studies), Yata 1111, Mishima, Shizuoka 411-8540, Japan. (6) Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK (7) Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK * Equal contribution ** Correspondence: Tony Ly: [email protected]; Helfrid Hochegger: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/501684; this version posted December 20, 2018.
    [Show full text]
  • Activation of Diverse Signalling Pathways by Oncogenic PIK3CA Mutations
    ARTICLE Received 14 Feb 2014 | Accepted 12 Aug 2014 | Published 23 Sep 2014 DOI: 10.1038/ncomms5961 Activation of diverse signalling pathways by oncogenic PIK3CA mutations Xinyan Wu1, Santosh Renuse2,3, Nandini A. Sahasrabuddhe2,4, Muhammad Saddiq Zahari1, Raghothama Chaerkady1, Min-Sik Kim1, Raja S. Nirujogi2, Morassa Mohseni1, Praveen Kumar2,4, Rajesh Raju2, Jun Zhong1, Jian Yang5, Johnathan Neiswinger6, Jun-Seop Jeong6, Robert Newman6, Maureen A. Powers7, Babu Lal Somani2, Edward Gabrielson8, Saraswati Sukumar9, Vered Stearns9, Jiang Qian10, Heng Zhu6, Bert Vogelstein5, Ben Ho Park9 & Akhilesh Pandey1,8,9 The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing ‘driver’ oncogenic mutations of PIK3CA to dissect the signalling mechanisms responsible for oncogenic phenotypes induced by mutant PIK3CA. From 8,075 unique phosphopeptides identified, we observe that aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signalling networks. Here, by integrating phosphoproteomic data with human protein microarray-based AKT1 kinase assays, we discover and validate six novel AKT1 substrates, including cortactin. Through mutagenesis studies, we demonstrate that phosphorylation of cortactin by AKT1 is important for mutant PI3K-enhanced cell migration and invasion. Our study describes a quantitative and global approach for identifying mutation-specific signalling events and for discovering novel signalling molecules as readouts of pathway activation or potential therapeutic targets. 1 McKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, 733 North Broadway, BRB 527, Baltimore, Maryland 21205, USA.
    [Show full text]
  • Anti-SORBS3 / Vinexin Antibody (ARG43064)
    Product datasheet [email protected] ARG43064 Package: 50 μg anti-SORBS3 / Vinexin antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes SORBS3 / Vinexin Tested Reactivity Hu, Ms, Rat Tested Application FACS, ICC/IF, IHC-P, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name SORBS3 / Vinexin Antigen Species Human Immunogen Synthetic peptide corresponding to a sequence of Human SORBS3 / Vinexin. (ASTKIPASQHTQNWSATWTKDSKRRDKRWVKYE) Conjugation Un-conjugated Alternate Names SH3-containing adapter molecule 1; Sorbin and SH3 domain-containing protein 3; SCAM-1; Vinexin; SCAM1; SH3D4 Application Instructions Application table Application Dilution FACS 1:150 - 1:500 ICC/IF 1:200 - 1:1000 IHC-P 1:200 - 1:1000 WB 1:500 - 1:2000 Application Note IHC-P: Antigen Retrieval: Heat mediation was performed in EDTA buffer (pH 8.0). * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 75 kDa Properties Form Liquid Purification Affinity purification with immunogen. Buffer 0.2% Na2HPO4, 0.9% NaCl, 0.05% Sodium azide and 4% Trehalose. Preservative 0.05% Sodium azide Stabilizer 4% Trehalose Concentration 0.5 mg/ml www.arigobio.com 1/4 Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use.
    [Show full text]
  • Anti-ERK1 + ERK2 Antibody (ARG20026)
    Product datasheet [email protected] ARG20026 Package: 50 μg, 25 μg anti-ERK1 + ERK2 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes ERK1 + ERK2 Tested Reactivity Hu, Ms, Rat, Chk, Sheep Tested Application ICC/IF, IP, WB Specificity The antibody recognizes 44 kDa and 42 kDa of endogeneous ERK1 + ERK2 (p44/p42 MAP kinase). Host Rabbit Clonality Polyclonal Isotype IgG Target Name ERK1 + ERK2 Antigen Species Rat Immunogen Synthetic peptide derived from Rat ERK2. Conjugation Un-conjugated Alternate Names MAPK 2; MAPK 1; MAP kinase 2; ERK-2; p41; ERK; MAP kinase 1; PRKM2; PRKM1; EC 2.7.11.24; MAPK2; p40; Extracellular signal-regulated kinase 2; p38; Mitogen-activated protein kinase 2; Mitogen-activated protein kinase 1; ERK2; MAP kinase isoform p42; p42-MAPK; P42MAPK; p41mapk; ERT1 Application Instructions Application table Application Dilution ICC/IF Assay-dependent IP 20-40 µg/ml WB 0.5-4 µg/ml Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 41 kDa Properties Form Liquid Purification Affinity Purified Antibody Buffer PBS (pH 7.2), 50% Glycerol, 1% BSA and 0.02% Thimerosal Preservative 0.02% Thimerosal Stabilizer 50% Glycerol, 1% BSA Concentration 1 mg/ml www.arigobio.com 1/3 Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening.
    [Show full text]
  • Dynamic Changes of Muscle Insulin Sensitivity After Metabolic Surgery
    ARTICLE https://doi.org/10.1038/s41467-019-12081-0 OPEN Dynamic changes of muscle insulin sensitivity after metabolic surgery Sofiya Gancheva1,2,3,11, Meriem Ouni 3,4,11, Tomas Jelenik2,3, Chrysi Koliaki1,2,3,5, Julia Szendroedi1,2,3, Frederico G.S. Toledo6, Daniel F. Markgraf 2,3, Dominik H. Pesta 2,3, Lucia Mastrototaro2,3, Elisabetta De Filippo2,3, Christian Herder 1,2,3, Markus Jähnert 3,4, Jürgen Weiss3,7, Klaus Strassburger 3,8, Matthias Schlensak9, Annette Schürmann 3,4,10,12 & Michael Roden 1,2,3,12 1234567890():,; The mechanisms underlying improved insulin sensitivity after surgically-induced weight loss are still unclear. We monitored skeletal muscle metabolism in obese individuals before and over 52 weeks after metabolic surgery. Initial weight loss occurs in parallel with a decrease in muscle oxidative capacity and respiratory control ratio. Persistent elevation of intramyocel- lular lipid intermediates, likely resulting from unrestrained adipose tissue lipolysis, accom- panies the lack of rapid changes in insulin sensitivity. Simultaneously, alterations in skeletal muscle expression of genes involved in calcium/lipid metabolism and mitochondrial function associate with subsequent distinct DNA methylation patterns at 52 weeks after surgery. Thus, initial unfavorable metabolic changes including insulin resistance of adipose tissue and skeletal muscle precede epigenetic modifications of genes involved in muscle energy metabolism and the long-term improvement of insulin sensitivity. 1 Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany. 2 Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, Düsseldorf, Germany. 3 German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
    [Show full text]
  • Androgen-Dependent Alternative Mrna Isoform Expression in Prostate Cancer Cells[Version 1; Peer Review: 3 Approved]
    F1000Research 2018, 7:1189 Last updated: 21 AUG 2021 RESEARCH ARTICLE Androgen-dependent alternative mRNA isoform expression in prostate cancer cells [version 1; peer review: 3 approved] Jennifer Munkley 1, Teresa M. Maia2,3, Nekane Ibarluzea1,4,5, Karen E. Livermore1, Daniel Vodak6, Ingrid Ehrmann1, Katherine James7,8, Prabhakar Rajan9, Nuno L. Barbosa-Morais2, David J. Elliott1 1Institute of Genetic Medicine, University of Newcastle, Newcastle upon Tyne, Newcastle, NE1 3BZ, UK 2Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, 1649-028, Portugal 3VIB Proteomics Core, Albert Baertsoenkaai 3, Ghent, 9000, Belgium 4Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, 48903, Spain 5Centre for Biomedical Research on Rare Diseases (CIBERER), ISCIII, Valencia, 46010, Spain 6Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway 7Interdisciplinary Computing and Complex BioSystems Research Group, Newcastle University, Newcastle upon Tyne, NE4 5TG, UK 8Life and Earth Sciences, Natural History Museum, Cromwell Road, London, SW7 5BD, UK 9Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, EC1M 6BQ, UK v1 First published: 03 Aug 2018, 7:1189 Open Peer Review https://doi.org/10.12688/f1000research.15604.1 Latest published: 03 Aug 2018, 7:1189 https://doi.org/10.12688/f1000research.15604.1 Reviewer Status Invited Reviewers Abstract Background: Androgen steroid hormones are key drivers of prostate 1 2 3 cancer. Previous work has shown that androgens can drive the expression of alternative mRNA isoforms as well as transcriptional version 1 changes in prostate cancer cells. Yet to what extent androgens control 03 Aug 2018 report report report alternative mRNA isoforms and how these are expressed and differentially regulated in prostate tumours is unknown.
    [Show full text]
  • SORBS3 / SCAM1 (1-329, His-Tag) Human Protein – AR51324PU-N | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for AR51324PU-N SORBS3 / SCAM1 (1-329, His-tag) Human Protein Product data: Product Type: Recombinant Proteins Description: SORBS3 / SCAM1 (1-329, His-tag) human recombinant protein, 0.1 mg Species: Human Expression Host: E. coli Tag: His-tag Predicted MW: 39.1 kDa Concentration: lot specific Purity: >90% by SDS - PAGE Buffer: Presentation State: Purified State: Liquid purified protein Buffer System: 20 mM Tris-HCl buffer (pH8.0) containing 20% glycerol, 1mM DTT Preparation: Liquid purified protein Protein Description: Recombinant human SORBS3 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography. Storage: Store undiluted at 2-8°C for one week or (in aliquots) at -20°C to -80°C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. RefSeq: NP_001018003 Locus ID: 10174 UniProt ID: O60504 Cytogenetics: 8p21.3 Synonyms: SCAM-1; SCAM1; SH3D4 Summary: This gene encodes an SH3 domain-containing adaptor protein. The presence of SH3 domains play a role in this protein's ability to bind other cytoplasmic molecules and contribute to cystoskeletal organization, cell adhesion and migration, signaling, and gene expression. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011] This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 SORBS3 / SCAM1 (1-329, His-tag) Human Protein – AR51324PU-N Product images: This product is to be used for laboratory only.
    [Show full text]
  • Research 1..8
    Article pubs.acs.org/jpr Proteome Atlas of Human Chromosome 8 and Its Multiple 8p Deficiencies in Tumorigenesis of the Stomach, Colon, and Liver † ○ † ○ ‡ § ○ ∥ ○ † † † Yang Zhang, , Guoquan Yan, , Linhui Zhai, , , Shaohang Xu, , Huali Shen, Jun Yao, Feifei Wu, † # † † † ‡ § ‡ § Liqi Xie, Hailin Tang, Hongxiu Yu, Mingqi Liu, Pengyuan Yang, Ping Xu, , Chengpu Zhang, , ‡ § ‡ § ‡ § ‡ § ‡ § ∥ ⊥ ∥ Liwei Li, , Cheng Chang, , Ning Li, , Songfeng Wu, , Yunping Zhu, , Quanhui Wang, , Bo Wen, ∥ ∥ ∥ □ † ∥ ⊥ ‡ § Liang Lin, Yinzhu Wang, Guiyan Zheng, Lanping Zhou, Haojie Lu,*, Siqi Liu,*, , Fuchu He,*, , † and Fan Zhong*, † Institutes of Biomedical Sciences and Department of Chemistry, Fudan University, Shanghai 200032, China ‡ State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 102206, China § National Engineering Research Center for Protein Drugs, Beijing 102206, China ∥ BGI-Shenzhen, Shenzhen 518083, China ⊥ Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, China # College of Mechanical & Electronic Engineering and Automatization, National University of Defense Technology, Changsha 410073, China □ State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China *S Supporting Information ABSTRACT: Chromosome 8, a medium-length euchromatic unit in humans that has an extraordinarily high mutation rate, can be detected not only in evolution but also in multiple
    [Show full text]